Barry M. Berger, MD, FACP, chief medical officer, Exact Sciences, discusses the significance and benefits of the Cologuard screening test for colorectal cancer.
Barry M. Berger, MD
Advertisement
Articles by Barry M. Berger, MD
Barry M. Berger, MD, FACP, chief medical officer, Exact Sciences, discusses a study demonstrating the benefit of utilization of the Cologuard screening test for colorectal cancer (CRC).
Advertisement
Latest Updated Articles
Dr. Berger on the Significance of the Cologuard Screening TestPublished: July 1st 2016 | Updated:
Dr. Berger on Noninvasive Screening Tool for CRCPublished: April 19th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
2
NCCN Guidelines Recognize MammaPrint/BluePrint for Determining Anthracycline Benefit in Breast Cancer
3
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
4
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
5